{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T20:02:08Z","timestamp":1772308928887,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1124\/jpet.108.144568","type":"journal-article","created":{"date-parts":[[2008,9,12]],"date-time":"2008-09-12T20:53:49Z","timestamp":1221252829000},"page":"969-981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"title":["Comparison of the Novel Subtype-Selective GABAA Receptor-Positive Allosteric Modulator NS11394 [3\u2032-[5-(1-Hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile] with Diazepam, Zolpidem, Bretazenil, and Gaboxadol in Rat Models of Inflammatory and Neuropathic Pain"],"prefix":"10.1016","volume":"327","author":[{"given":"G.","family":"Munro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Lopez-Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Rivera-Arconada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.K.","family":"Erichsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.\u00d8.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.S.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.K.","family":"Ahring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.R.","family":"Mirza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.108.144568_bib1","doi-asserted-by":"crossref","unstructured":"Akagi H and Yanagisawa M (1987) GABAergic modulation of a substance P-mediated reflex of slow time course in the isolated rat spinal cord. Br J Pharmacol 91: 189-197.","DOI":"10.1111\/j.1476-5381.1987.tb08998.x"},{"key":"10.1124\/jpet.108.144568_bib2","doi-asserted-by":"crossref","unstructured":"Bennett GJ and Xie YK (1988) A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33: 87-107.","DOI":"10.1016\/0304-3959(88)90209-6"},{"key":"10.1124\/jpet.108.144568_bib3","doi-asserted-by":"crossref","unstructured":"Bohlhalter S, Weinmann O, Mohler H, and Fritschy JM (1996) Laminar compartmentalization of GABAA-receptor subtypes in the spinal cord: an immunohistochemical study. J Neurosci 16: 283-297.","DOI":"10.1523\/JNEUROSCI.16-01-00283.1996"},{"key":"10.1124\/jpet.108.144568_bib4","doi-asserted-by":"crossref","unstructured":"Castro-Lopes JM, Malcangio M, Pan BH, and Bowery NG (1995) Complex changes of GABAA and GABAB receptor binding in the spinal cord dorsal horn following peripheral inflammation or neurectomy. Brain Res 679: 289-297.","DOI":"10.1016\/0006-8993(95)00262-O"},{"key":"10.1124\/jpet.108.144568_bib5","doi-asserted-by":"crossref","unstructured":"Castro-Lopes JM, Tavares I, and Coimbra A (1993) GABA decreases in the spinal cord dorsal horn after peripheral neurectomy. Brain Res 620: 287-291.","DOI":"10.1016\/0006-8993(93)90167-L"},{"key":"10.1124\/jpet.108.144568_bib6","doi-asserted-by":"crossref","unstructured":"Chandra D, Jia F, Liang J, Peng Z, Suryanarayanan A, Werner DF, Spigelman I, Houser CR, Olsen RW, Harrison NL, et al. (2006) GABAA receptor alpha 4 subunits mediate extrasynaptic inhibition in thalamus and dentate gyrus and the action of gaboxadol. Proc Natl Acad Sci U S A 103: 15230-15235.","DOI":"10.1073\/pnas.0604304103"},{"key":"10.1124\/jpet.108.144568_bib7","doi-asserted-by":"crossref","unstructured":"Coderre TJ, Katz J, Vaccarino AL, and Melzack R (1993) Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 52: 259-285.","DOI":"10.1016\/0304-3959(93)90161-H"},{"key":"10.1124\/jpet.108.144568_bib8","doi-asserted-by":"crossref","unstructured":"Cremers T and Ebert B (2007) Plasma and CNS concentrations of gaboxadol in rats following subcutaneous administration. Eur J Pharmacol 562: 47-52.","DOI":"10.1016\/j.ejphar.2007.01.017"},{"key":"10.1124\/jpet.108.144568_bib9","doi-asserted-by":"crossref","unstructured":"Decosterd I and Woolf CJ (2000) Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 87: 149-158.","DOI":"10.1016\/S0304-3959(00)00276-1"},{"key":"10.1124\/jpet.108.144568_bib10","doi-asserted-by":"crossref","unstructured":"Dirig DM and Yaksh TL (1995) Intrathecal baclofen and muscimol, but not midazolam, are antinociceptive using the rat-formalin model. J Pharmacol Exp Ther 275: 219-227.","DOI":"10.1016\/S0022-3565(25)12039-9"},{"key":"10.1124\/jpet.108.144568_bib11","doi-asserted-by":"crossref","unstructured":"Ebert B, Wafford KA, and Deacon S (2006) Treating insomnia: current and investigational pharmacological approaches. Pharmacol Ther 112: 612-629.","DOI":"10.1016\/j.pharmthera.2005.04.014"},{"key":"10.1124\/jpet.108.144568_bib12","doi-asserted-by":"crossref","unstructured":"Griebel G, Perrault G, Letang V, Granger P, Avenet P, Schoemaker H, and Sanger DJ (1999a) New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes. Psychopharmacology (Berl) 146: 205-213.","DOI":"10.1007\/s002130051108"},{"key":"10.1124\/jpet.108.144568_bib13","doi-asserted-by":"crossref","unstructured":"Griebel G, Perrault G, and Sanger DJ (1999b) Study of the modulatory activity of BZ (omega) receptor ligands on defensive behaviors in mice: evaluation of the importance of intrinsic efficacy and receptor subtype selectivity. Prog Neuropsychopharmacol Biol Psychiatry 23: 81-98.","DOI":"10.1016\/S0278-5846(98)00093-1"},{"key":"10.1124\/jpet.108.144568_bib14","doi-asserted-by":"crossref","unstructured":"Haefely W, Martin JR, and Schoch P (1990) Novel anxiolytics that act as partial agonists at benzodiazepine receptors. Trends Pharmacol Sci 11: 452-456.","DOI":"10.1016\/0165-6147(90)90126-S"},{"key":"10.1124\/jpet.108.144568_bib15","doi-asserted-by":"crossref","unstructured":"Hedo G and Lopez-Garcia JA (2001) Alpha-1A adrenoceptors modulate potentiation of spinal nociceptive pathways in the rat spinal cord in-vitro. Neuropharmacology 41: 862-869.","DOI":"10.1016\/S0028-3908(01)00117-4"},{"key":"10.1124\/jpet.108.144568_bib16","doi-asserted-by":"crossref","unstructured":"Henry JL, Yashpal K, Pitcher GM, and Coderre TJ (1999) Physiological evidence that the `interphase\u2019 in the formalin test is due to active inhibition. Pain 82: 57-63.","DOI":"10.1016\/S0304-3959(99)00033-0"},{"key":"10.1124\/jpet.108.144568_bib17","doi-asserted-by":"crossref","unstructured":"Hwang JH and Yaksh TL (1997) The effect of spinal GABA receptor agonists on tactile allodynia in a surgically-induced neuropathic pain model in the rat. Pain 70: 15-22.","DOI":"10.1016\/S0304-3959(96)03249-6"},{"key":"10.1124\/jpet.108.144568_bib18","doi-asserted-by":"crossref","unstructured":"Kaneko M and Hammond DL (1997) Role of spinal gamma-aminobutyric acidA receptors in formalin-induced nociception in the rat. J Pharmacol Exp Ther 282: 928-938.","DOI":"10.1016\/S0022-3565(24)36830-2"},{"key":"10.1124\/jpet.108.144568_bib19","doi-asserted-by":"crossref","unstructured":"Knabl J, Witschi R, H\u00f6sl K, Reinold H, Zeilhofer UB, Ahmadi S, Brockhaus J, Sergejeva M, Hess A, Brune K, et al. (2008) Reversal of pathological pain through specific spinal GABAA receptor subtypes. Nature 451: 330-334.","DOI":"10.1038\/nature06493"},{"key":"10.1124\/jpet.108.144568_bib20","doi-asserted-by":"crossref","unstructured":"LaGraize SC and Fuchs PN (2007) GABAA but not GABAB receptors in the rostral anterior cingulate cortex selectively modulate pain-induced escape\/avoidance behavior. Exp Neurol 204: 182-194.","DOI":"10.1016\/j.expneurol.2006.10.007"},{"key":"10.1124\/jpet.108.144568_bib21","doi-asserted-by":"crossref","unstructured":"Malan TP, Mata HP, and Porreca F (2002) Spinal GABA(A) and GABA(B) receptor pharmacology in a rat model of neuropathic pain. Anesthesiology 96: 1161-1167.","DOI":"10.1097\/00000542-200205000-00020"},{"key":"10.1124\/jpet.108.144568_bib22","doi-asserted-by":"crossref","unstructured":"Malcangio M and Bowery NG (1996) GABA and its receptors in the spinal cord. Trends Pharmacol Sci 17: 457-462.","DOI":"10.1016\/S0165-6147(96)01013-9"},{"key":"10.1124\/jpet.108.144568_bib23","doi-asserted-by":"crossref","unstructured":"McNamara CR, Mandel-Brehm J, Bautista DM, Siemens J, Deranian KL, Zhao M, Hayward NJ, Chong JA, Julius D, Moran MM, et al. (2007) TRPA1 mediates formalin-induced pain. Proc Natl Acad Sci U S A 104: 13525-13530.","DOI":"10.1073\/pnas.0705924104"},{"key":"10.1124\/jpet.108.144568_bib24","doi-asserted-by":"crossref","unstructured":"Mirza NR and Nielsen E\u00d8 (2006) Do subtype-selective gamma-aminobutyric acid A receptor modulators have a reduced propensity to induce physical dependence in mice? J Pharmacol Exp Ther 316: 1378-1385.","DOI":"10.1124\/jpet.105.094474"},{"key":"10.1124\/jpet.108.144568_bib25","doi-asserted-by":"crossref","unstructured":"Mirza NR, Larsen JS, Mathiasen C, Jacobsen TA, Munro G, Erichsen HK, Nielsen AN, Nielsen E\u00d8, and Ahring PK (2008) NS11394 [3\u2032-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile], a unique subtype-selective GABAA receptor positive allosteric modulator: in vitro actions, pharmacokinetic properties, and in vivo anxiolytic efficacy. J Pharmacol Exp Ther 327: 954-968.","DOI":"10.1124\/jpet.108.138859"},{"key":"10.1124\/jpet.108.144568_bib26","doi-asserted-by":"crossref","unstructured":"Moore KA, Kohno T, Karchewski LA, Scholz J, Baba H, and Woolf CJ (2002) Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord. J Neurosci 22: 6724-6731.","DOI":"10.1523\/JNEUROSCI.22-15-06724.2002"},{"key":"10.1124\/jpet.108.144568_bib27","doi-asserted-by":"crossref","unstructured":"Munro G, Baek C, Erichsen HK, Nielsen AN, Nielsen E\u00d8, Scheel-Kruger J, Weikop P, and Peters D (2008) The novel compound (+\/-)-1-[10-((E)-3-phenyl-allyl)-3,10-diaza-bicyclo[4.3.1]dec-3-yl]-propan-1-one (NS7051) attenuates nociceptive transmission in animal models of experimental pain; a pharmacological comparison with the combined mu-opioid receptor agonist and monoamine reuptake inhibitor tramadol. Neuropharmacology 54: 331-343.","DOI":"10.1016\/j.neuropharm.2007.10.005"},{"key":"10.1124\/jpet.108.144568_bib28","doi-asserted-by":"crossref","unstructured":"Paronis CA, Cox ED, Cook JM, and Bergman J (2001) Different types of GABA(A) receptors may mediate the anticonflict and response rate-decreasing effects of zaleplon, zolpidem and midazolam in squirrel monkeys. Psychopharmacology (Berl) 156: 461-468.","DOI":"10.1007\/s002130100754"},{"key":"10.1124\/jpet.108.144568_bib29","doi-asserted-by":"crossref","unstructured":"Pedersen LH, Scheel-Kr\u00fcger J, and Blackburn-Munro G (2007) Amygdala GABA-A receptor involvement in mediating sensory-discriminative and affective-motivational pain responses in a rat model of peripheral nerve injury. Pain 127: 17-26.","DOI":"10.1016\/j.pain.2006.06.036"},{"key":"10.1124\/jpet.108.144568_bib30","doi-asserted-by":"crossref","unstructured":"Poisbeau P, Patte-Mensah C, Keller AF, Barrot M, Breton JD, Luis-Delgado OE, Freund-Mercier MJ, Mensah-Nyagan AG, and Schlichter R (2005) Inflammatory pain upregulates spinal inhibition via endogenous neurosteroid production. J Neurosci 25: 11768-11776.","DOI":"10.1523\/JNEUROSCI.3841-05.2005"},{"key":"10.1124\/jpet.108.144568_bib31","doi-asserted-by":"crossref","unstructured":"Rivera-Arconada I and Lopez-Garcia JA (2006) Retigabine-induced population primary afferent hyperpolarisation in-vitro. Neuropharmacology 51: 756-763.","DOI":"10.1016\/j.neuropharm.2006.05.015"},{"key":"10.1124\/jpet.108.144568_bib32","doi-asserted-by":"crossref","unstructured":"Rudolph U and M\u00f6hler H (2006) GABA-based therapeutic approaches: GABAA receptor subtype functions. Curr Opin Pharmacol 6: 18-23.","DOI":"10.1016\/j.coph.2005.10.003"},{"key":"10.1124\/jpet.108.144568_bib33","doi-asserted-by":"crossref","unstructured":"Rudomin P and Schmidt RF (1999) Presynaptic inhibition in the vertebrate spinal cord revisited. Exp Brain Res 129: 1-37.","DOI":"10.1007\/s002210050933"},{"key":"10.1124\/jpet.108.144568_bib34","doi-asserted-by":"crossref","unstructured":"Sanger DJ and Benavides J (1993) Discriminative stimulus effects of omega (BZ) receptor ligands: correlation with in-vivo inhibition of [3H]-flumazenil binding in different regions of the rat central nervous system. Psychopharmacology (Berl) 111: 315-322.","DOI":"10.1007\/BF02244947"},{"key":"10.1124\/jpet.108.144568_bib35","doi-asserted-by":"crossref","unstructured":"Siarey RJ, Long SK, and Evans RH (1992) The effects of centrally acting myorelaxants on NMDA receptor-mediated synaptic transmission in the immature rat spinal cord in-vitro. Br J Pharmacol 107: 628-633.","DOI":"10.1111\/j.1476-5381.1992.tb12794.x"},{"key":"10.1124\/jpet.108.144568_bib36","doi-asserted-by":"crossref","unstructured":"Siarey RJ, Long SK, Tulp MT, and Evans RH (1994) The effects of central myorelaxants on synaptically-evoked primary afferent depolarization in the immature rat spinal cord in-vitro. Br J Pharmacol 111: 497-502.","DOI":"10.1111\/j.1476-5381.1994.tb14764.x"},{"key":"10.1124\/jpet.108.144568_bib37","doi-asserted-by":"crossref","unstructured":"Sieghart W (1995) Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes. Pharmacol Rev 47: 181-234.","DOI":"10.1016\/S0031-6997(25)06840-1"},{"key":"10.1124\/jpet.108.144568_bib38","doi-asserted-by":"crossref","unstructured":"Simjee SU, Pleuvry BJ, and Coulthard P (2004) Modulation of the gait deficit in arthritic rats by infusions of muscimol and bicuculline. Pain 109: 453-460.","DOI":"10.1016\/j.pain.2004.02.022"},{"key":"10.1124\/jpet.108.144568_bib39","doi-asserted-by":"crossref","unstructured":"Squires RF, Benson DI, Braestrup C, Coupet J, Klepner CA, Myers V, and Beer B (1979) Some properties of brain specific benzodiazepine receptors: new evidence for multiple receptors. Pharmacol Biochem Behav 10: 825-830.","DOI":"10.1016\/0091-3057(79)90341-1"},{"key":"10.1124\/jpet.108.144568_bib40","doi-asserted-by":"crossref","unstructured":"Xiao HS, Huang QH, Zhang FX, Bao L, Lu YJ, Guo C, Yang L, Huang WJ, Fu G, Xu SH, et al. (2002) Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain. Proc Natl Acad Sci U S A 99: 8360-8365.","DOI":"10.1073\/pnas.122231899"},{"key":"10.1124\/jpet.108.144568_bib41","doi-asserted-by":"crossref","unstructured":"Yang L, Zhang FX, Huang F, Lu YJ, Li GD, Bao L, Xiao HS, and Zhang X (2004) Peripheral nerve injury induces trans-synaptic modification of channels, receptors and signal pathways in rat dorsal spinal cord. Eur J Neurosci 19: 871-883.","DOI":"10.1111\/j.0953-816X.2004.03121.x"},{"key":"10.1124\/jpet.108.144568_bib42","doi-asserted-by":"crossref","unstructured":"Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109-110.","DOI":"10.1016\/0304-3959(83)90201-4"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524347238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524347238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.108.144568","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:48:24Z","timestamp":1739987304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524347238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0022356524347238"],"URL":"https:\/\/doi.org\/10.1124\/jpet.108.144568","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1144844.601930","asserted-by":"object"}]},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the Novel Subtype-Selective GABAA Receptor-Positive Allosteric Modulator NS11394 [3\u2032-[5-(1-Hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile] with Diazepam, Zolpidem, Bretazenil, and Gaboxadol in Rat Models of Inflammatory and Neuropathic Pain","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.108.144568","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2008 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}